Login

Dr Hezrin Shahrin

Centre for Cancer Biology Centre for Cancer Biology

email Hezrin.Shahrin@unisa.edu.au

Research

Research focus

Clinical Sciences
Cardiovascular Medicine and Haematology
Oncology and Carcinogenesis
Biochemistry and Cell Biology
Genetics

Research

Outputs

Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included.

Open access indicates that an output is open access.

Journal Articles

Year	Output
2024	Branford, S, Fernandes, A, Shahrin, NH, Maqsood, M, Shanmuganathan, N & Wadham, C 2024, 'Beyond BCR::ABL1-the role of genomic analyses in the management of CML', Journal of the National Comprehensive Cancer Network, vol. 22, no. 1, pp. 1-9.
2023	Shanmuganathan, N, Wadham, C, Shahrin, NH, Feng, J, Thomson, D, Wang, P, Kok, CH, King, RM, Kenyon, RR, Lin, M, Ross, DM, Yeung, DT, Scott, HS, Schreiber, AW & Branford, S and 9 other authors 2023, 'Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention', Haematologica: The Hematology Journal, vol. 108, no. 9, pp. 2380-2395. Open access 3 4 15
2022	Shahrin, NH, Wadham, C & Branford, S 2022, 'Defining higher-risk chronic myeloid leukemia: risk scores, genomic landscape, and prognostication', Current Hematologic Malignancy Reports, vol. 17, no. 6, pp. 171-180. Open access 8 4
2022	Shanmuganathan, N, Wadham, C, Thomson, D, Shahrin, NH, Vignaud, C, Obourn, V, Chaturvedi, S, Yang, F, Feng, J, Saunders, V, Kok, CH, Yeung, D, King, RM, Kenyon, RR, Lin, M, Wang, P, Scott, H, Hughes, T, Schreiber, AW & Branford, S 2022, 'RNA-based targeted gene sequencing improves the diagnostic yield of mutant detection in chronic myeloid leukemia', Journal of Molecular Diagnostics, vol. 24, no. 7, pp. 803-822. Open access 3 4 3
2021	Homan, CC, Venugopal, P, Arts, P, Shahrin, NH, Feurstein, S, Rawlings, L, Lawrence, DM, Andrews, J, King-Smith, SL, Harvey, NL, Brown, AL, Scott, HS & Hahn, CN 2021, 'GATA2 deficiency syndrome: a decade of discovery', Human Mutation, vol. 42, no. 11, pp. 1399-1421. Open access 34 31 9
2020	Thomson, DW, Shahrin, NH, Wang, PP, Wadham, C, Shanmuganathan, N, Scott, HS, Dinger, ME, Hughes, TP, Schreiber, AW & Branford, S 2020, 'Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia', Leukemia, vol. 34, no. 8, pp. 2051-2063. Open access 29 29 1
2018	Branford, S, Wang, P, Yeung, DT, Thomson, D, Wadham, C, Shahrin, NH, Marum, JE, Nataren, N, Parker, WT, Shanmuganathan, N, Donaldson, Z, Altamura, H, Georgievski, J, Brown, A, Hahn, C, White, DL, Scott, HS, Schreiber, AW & Hughes, TP and 18 other authors 2018, 'Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease', Blood, vol. 132, no. 9, pp. 948-961. Open access 147 142 8
2016	Dawar, S, Shahrin, NH, Sladojevic, N, D'Andrea, R, Dorstyn, L, Hiwase, DK & Kumar, S 2016, 'Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice', Cell Death and Disease, vol. 7, no. e2509, pp.1-9. Open access 24 25 10

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Novartis Institutes for Biomedical Research	UNITED STATES
Novartis Pharmaceuticals	UNITED STATES
Royal Adelaide Hospital	AUSTRALIA
SA Pathology	AUSTRALIA
South Australian Health and Medical and Research Institute (SAHMRI)	AUSTRALIA
University of Adelaide	AUSTRALIA
University of Chicago	UNITED STATES
University of New South Wales	AUSTRALIA
University of South Australia	AUSTRALIA

more less